Archives

Summary Cleveland-Cliffs’ consolidated revenues were US$4.0 billion in Q1 of 2021. Rio Tinto reported a 30% increase in adjusted EBITDA in Q1. Freeport McMoRan posted revenue of US$4850 million in the first quarter. Trading in preci...

• May 20, 2021 08:50 PM PDT
• Team Kalkine Media

Summary Sales, excluding gasoline, increased marginally by 0.3% in Q1, compared to the year-ago period. The retailer has a strong presence on the US eastern coast; it currently has 221 clubs and 151 BJ's gas stations in 17 states. Gross profit...

• May 20, 2021 07:52 PM PDT
• Team Kalkine Media

Summary WeWork’s total occupancy plummeted 50% in Q1 compared to 47% in the fourth quarter. Its first-quarter revenue of US$598 million was nearly half the proceeds in the year-ago period. WeWork’s clients declined by 41% to 490,00...

• May 20, 2021 07:12 PM PDT
• Team Kalkine Media

Summary Kohl’s revenue soared 60.1 percent year-over-year in the first quarter. The retailer posted income of US$14 million, or 9 cents per share. Kohl’s stock surged 47 percent YTD. Kohl’s Corporation (NYSE:KSS) stock p...

• May 20, 2021 04:58 PM PDT
• Team Kalkine Media

Summary Lightspeed forecasts revenue in the range of US$430 to US$450 million for the fiscal year 2022. In fiscal 2021, revenue soared 84 percent year over year. The Canadian company’s stock is up 107 percent since the NYSE listing. ...

• May 20, 2021 04:40 PM PDT
• Kiran Murali

Summary The space tourism company to conduct a spaceflight test this Saturday. Virgin Galactic first attempted the spaceflight test in December 2020. The company’s stock is down 18.7 percent year to date. Virgin Galactic Holdings, I...

• May 20, 2021 04:07 PM PDT
• Team Kalkine Media

Summary Oatly stock (NASDAQ: OTLY) soared 22.97% to US$20.9 at 2:48 pm ET on Thursday, May 20. Oatly raised US$1.4 billion from 84.4 million American depositary shares at an offering price of US$17 apiece on Wednesday, bringing its valuation to...

• May 20, 2021 12:52 PM PDT
• Team Kalkine Media

Summary The stock boost comes after Iovance revealed that its new cancer drug showed positive results. Iovance can apply for a biologics license, which may happen in 2022, after FDA approval. The company develops treatment for patients with tu...

• May 20, 2021 12:44 PM PDT
• Team Kalkine Media